Insider Trading Alert - PRXL, BLK And BYI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 12, 2014, 128 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $79.73 to $121,490,730.00.

Highlighted Stocks Traded by Insiders:

Parexel International Corporation (PRXL) - FREE Research Report

Von Rickenbach Josef H who is Chairman & CEO at Parexel International Corporation sold 50,000 shares at $49.76 on Feb. 12, 2014. Following this transaction, the Chairman & CEO owned 562,641 shares meaning that the stake was reduced by 8.16% with the 50,000-share transaction.

Callow A Dana Jr who is Director at Parexel International Corporation sold 10,000 shares at $49.40 on Feb. 12, 2014. Following this transaction, the Director owned 33,990 shares meaning that the stake was reduced by 22.73% with the 10,000-share transaction.

The shares most recently traded at $51.66, up $2.26, or 4.37% since the insider transaction. Historical insider transactions for Parexel International Corporation go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 79,529
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 79,529
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 86,529

The average volume for Parexel International Corporation has been 672,500 shares per day over the past 30 days. Parexel International Corporation has a market cap of $2.8 billion and is part of the health care sector and health services industry. Shares are up 12.17% year-to-date as of the close of trading on Wednesday.

PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 25.5. Currently there are 5 analysts that rate Parexel International Corporation a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings rates Parexel International Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Parexel International Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BlackRock (BLK) - FREE Research Report

Fairbairn Robert W who is Senior Managing Director at BlackRock sold 4,500 shares at $300.00 on Feb. 12, 2014. Following this transaction, the Senior Managing Director owned 75,103 shares meaning that the stake was reduced by 5.65% with the 4,500-share transaction.

The shares most recently traded at $304.39, up $4.39, or 1.44% since the insider transaction. Historical insider transactions for BlackRock go as follows:

  • 4-Week # shares sold: 6,650
  • 12-Week # shares sold: 6,650
  • 24-Week # shares sold: 6,650

The average volume for BlackRock has been 683,500 shares per day over the past 30 days. BlackRock has a market cap of $51.0 billion and is part of the financial sector and financial services industry. Shares are down 4.1% year-to-date as of the close of trading on Wednesday.

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors. The stock currently has a dividend yield of 2.53%. The company has a P/E ratio of 18.4. Currently there are 6 analysts that rate BlackRock a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BLK - FREE

TheStreet Quant Ratings rates BlackRock as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full BlackRock Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Bally Technologies (BYI) - FREE Research Report

Srinivasan Ramesh who is President & CEO at Bally Technologies bought 15,000 shares at $67.54 on Feb. 12, 2014. Following this transaction, the President & CEO owned 105,936 shares meaning that the stake was reduced by 16.5% with the 15,000-share transaction.

The shares most recently traded at $69.20, up $1.66, or 2.39% since the insider transaction. Historical insider transactions for Bally Technologies go as follows:

  • 4-Week # shares sold: 25,000
  • 12-Week # shares sold: 50,176
  • 24-Week # shares sold: 98,793

The average volume for Bally Technologies has been 472,900 shares per day over the past 30 days. Bally Technologies has a market cap of $2.6 billion and is part of the services sector and leisure industry. Shares are down 14.42% year-to-date as of the close of trading on Wednesday.

Bally Technologies, Inc., a gaming company, designs, manufactures, operates, and distributes advanced technology-based gaming devices, systems, server-based solutions, custom mobile applications, and interactive applications in the United States and internationally. The company has a P/E ratio of 20.0. Currently there are 8 analysts that rate Bally Technologies a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BYI - FREE

TheStreet Quant Ratings rates Bally Technologies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Bally Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Stocks Trade Lower as Apple's Slump Offsets Gains in General Electric

Stocks Trade Lower as Apple's Slump Offsets Gains in General Electric

Skechers Slumps the Most in Two Years After Soft Guidance Overshadows Solid Q1

Skechers Slumps the Most in Two Years After Soft Guidance Overshadows Solid Q1

Video: This Is One Way Millennials Are Destroying Their Financial Future

Video: This Is One Way Millennials Are Destroying Their Financial Future

What Do Trade Wars Mean for High Yield Bond Investors?

What Do Trade Wars Mean for High Yield Bond Investors?